Selenoprotein P, rather than glutathione peroxidase, as a potential marker of septic shock and related syndromes

European Surgical Research

Volumn 43, Issue 4, 2009, Pages 338-347

  Forceville, X ^a   Mostert, V ^e   Pierantoni, A ^a   Vitoux, D ^b   Le Toumelin, P ^d   Plouvier, E ^a   Dehoux, M ^c   Thuillier, F ^a   Combes, A ^a  

^a CENTRE HOSPITALIER DE MEAUX   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c BICHAT HOSPITAL   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Antioxidants; Endothelium; Free radicals; Reactive oxygen species; Sepsis; Shock; Systemic inflammatory response syndrome

Indexed keywords

ALBUMIN; GLUTATHIONE PEROXIDASE; SELENIUM; SELENOPROTEIN P;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROTEIN BINDING; SEPTIC SHOCK; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PROGNOSIS; SELENIUM; SELENOPROTEIN P; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TIME FACTORS;

EID: 73349115229     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000239763     Document Type: Article

References (51)

1. Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet 2005; 365: 63-78.
2. Aird WC: The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003; 101: 3765-3777.
3. Spronk PE, Zandstra DF, Ince C: Bench-tobedside review: sepsis is a disease of the microcirculation. Crit Care 2004; 8: 462-468.
4. Berger MM, Chiolero RL: Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med 2007; 35(9 suppl):S584-S590.
5. Aird WC: Endothelium as an organ system. Crit Care Med 2004; 32(5 suppl):S271-S279.
6. Crimi E, Sica V, Williams-Ignarro S, Zhang H, Slutsky AS, Ignarro LJ, Napoli C: The role of oxidative stress in adult critical care. Free Radic Biol Med 2006; 40: 398-406.
7. Macdonald J, Galley HF, Webster NR: Oxidative stress and gene expression in sepsis. Br J Anaesth 2003; 90: 221-232.
8. Ince C: The microcirculation is the motor of sepsis. Crit Care 2005; 9(suppl 4):S13-S19.
9. Schouten M, Wiersinga WJ, Levi M, van der Poll T: Inflammation, endothelium, and coagulation in sepsis. J Leukoc Biol 2007.
10. Hauser B, Matejovic M, Radermacher P: Nitric oxide, leukocytes and microvascular permeability: causality or bystanders? Crit Care 2008; 12: 104.
11. Rayman MP: The importance of selenium to human health. Lancet 2000; 356: 233-241.
12. Halliwell B, Gutteridge JMC: Free Radicals in Biology and Medicine, ed 3. Oxford, Oxford University Press; 1999.
13. Stadtman TC: Selenocysteine. Annu Rev Biochem 1996, 65: 83-100.
14. Vincent JL, Forceville X: Critically elucidating the role of selenium. Curr Opin Anesthesiol 2008; 21: 148-154.
15. Levander OA, Beck MA: Interacting nutritional and infectious etiologies of Keshan disease. Insights from coxsackie virus B-induced myocarditis in mice deficient in selenium or vitamin E. Biol Trace Elem Res 1997; 56: 5-21.
16. Schomburg L, Schweizer U, Kohrle J: Selenium and selenoproteins in mammals: extraordinary, essential, enigmatic. Cell Mol Life Sci 2004; 61: 1988-1995.
17. Hatfield DL, Gladyshev VN: How selenium has altered our understanding of the genetic code. Mol Cell Biol 2002; 22: 3565-3576.
18. Mostert V: Selenoprotein P: properties, functions, and regulation. Arch Biochem Biophys 2000; 376: 433-438.
19. Burk RF, Hill KE: Selenoprotein P: an extracellular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr 2005; 25: 215-235.
20. Brigelius-Flohe R, Banning A, Schnurr K: Selenium-dependent enzymes in endothelial cell function. Antioxid Redox Signal 2003; 5: 205-215.
21. Hill KE, Xia Y, Akesson B, Boeglin ME, Burk RF: Selenoprotein P concentration in plasma is an index of selenium status in seleniumdeficient and selenium-supplemented Chinese subjects. J Nutr 1996,126: 138-145.
22. Persson-Moschos M, Huang W, Srikumar TS, Akesson B, Lindeberg S: Selenoprotein P in serum as a biochemical marker of selenium status. Analyst 1995; 120: 833-836.
23. Schomburg L, Schweizer U, Holtmann B, Flohe L, Sendtner M, Kohrle J: Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem J 2003; 9.
24. Hill KE, Zhou J, McMahan WJ, Motley AK, Atkins JF, Gesteland RF, Burk RF: Deletion of selenoprotein P alters distribution of selenium in the mouse. J Biol Chem 2003; 278: 13640-13646.
25. Steinbrenner H, Bilgic E, Alili L, Sies H, Brenneisen P: Selenoprotein P protects endothelial cells from oxidative damage by stimulation of glutathione peroxidase expression and activity. Free Radic Res 2006; 40: 936-943.
26. Burk RF, Hill KE, Motley AK: Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. J Nutr 2003; 133(5 suppl 1):1517S-1520S.
27. Saito Y, Sato N, Hirashima M, Takebe G, Nagasawa S, Takahashi K: Domain structure of bi-functional selenoprotein P. Biochem J 2004; 381(pt 3):841-846.
28. Arteel GE, Mostert V, Oubrahim H, Briviba K, Abel J, Sies H: Protection by selenoprotein P in human plasma against peroxynitritemediated oxidation and nitration. Biol Chem 1998; 379: 1201-1205. (Pubitemid 28456834)
29. Takebe G, Yarimizu J, Saito Y, Hayashi T, Nakamura H, Yodoi J, Nagasawa S, Takahashi K: A comparative study on the hydroperoxide and thiol specificity of the glutathione peroxidase family and selenoprotein P. J Biol Chem 2002; 277: 41254-41258.
30. Traulsen H, Steinbrenner H, Buchczyk DP, Klotz LO, Sies H: Selenoprotein P protects low-density lipoprotein against oxidation. Free Radic Res 2004; 38: 123-128.
31. Heyland DK, Dhaliwal R, Suchner U, Berger MM: Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 2005; 31: 327-337. Epub 2004 Dec 2017.
32. Forceville X: Selenium and the 'free' electron. Selenium - a trace to be followed in septic or inflammatory ICU patients? Intensive Care Med 2001; 27: 16-18.
33. Angstwurm MW, Gaertner R: Practicalities of selenium supplementation in critically ill patients. Curr Opin Clin Nutr Metab Care 2006; 9: 233-238.
34. Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, Meier-Hellmann A, Insel R, Radke J, et al: Selenium in Intensive Care (SIC): results of a prospective randomized, placebocontrolled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock. Crit Care Med 2007; 35: 118-126.
35. Forceville X, Vitoux D, Gauzit R, Combes A, Lahilaire P, Chappuis P: Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit Care Med 1998; 26: 1536-1544.
36. Sakr Y, Reinhart K, Bloos F, Marx G, Russwurm S, Bauer M, Brunkhorst F: Time course and relationship between plasma selenium concentrations, systemic inflammatory response, sepsis, and multiorgan failure. Br J Anaesth 2007; 98: 775-784.
37. Wang Z, Forceville X, Van Antwerpen P, Piagnerelli M, Ahishakiye D, Macours P, De Backer D, Neve J, Vincent JL: A large bolus, but not a continuous infusion, of sodium selenite improves outcome in peritonitis. Shock 2009; 32: 140-146.
38. Harrison I, Littlejohn D, Fell GS: Distribution of selenium in human blood plasma and serum. Analyst 1996; 121: 189-194.
39. Bone RC, Sibbald WJ, Sprung CL: The ACCP-SCCM consensus conference on sepsis and organ failure (editorial; comment). Chest 1992;101: 1481-1483.
40. Pastor CM, Suter PM: Hepatic hemodynamics and cell functions in human and experimental sepsis. Anesth Analg 1999; 89: 344-352.
41. Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, et al: The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med 1999; 25: 686-696.
42. Mostert V, Lombeck I, Abel J: A novel method for the purification of selenoprotein P from human plasma. Arch Biochem Biophys 1998; 357: 326-330.
43. Marchaluk E, Persson-Moschos M, Thorling EB, Akesson B: Variation in selenoprotein P concentration in serum from different European regions. Eur J Clin Nutr 1995; 49: 42-48.
44. Hollenbach B, Morgenthaler NG, Struck J, Alonso C, Bergmann A, Kohrle J, Schomburg L: New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. J Trace Elem Med Biol 2008; 22: 24-32.
45. Morgenthaler NG, Struck J, Alonso C, Bergmann A: Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006; 52: 112-119.
46. Mostert V, Dreher I, Kohrle J, Wolff S, Abel J: Modulation of selenoprotein P expression by TGF-β 1 is mediated by Smad proteins. Biofactors 2001; 14: 135-142.
47. Renko K, Hofmann PJ, Stoedter M, Hollenbach B, Behrends T, Kohrle J, Schweizer U, Schomburg L: Down-regulation of the hepatic selenoprotein biosynthesis machinery impairs selenium metabolism during the acute phase response in mice. FASEB J 2009.
48. Hawker FH, Stewart PM, Snitch PJ: Effects of acute illness on selenium homeostasis. Crit Care Med 1990; 18: 442-446.
49. Berger MM, Cavadini C, Chiolero R, Dirren H: Copper, selenium, and zinc status and balances after major trauma. J Trauma 1996; 40: 103-109. (Pubitemid 26045027)
50. Mishra V, Baines M, Perry SE, McLaughlin PJ, Carson J, Wenstone R, Shenkin A: Effect of selenium supplementation on biochemical markers and outcome in critically ill patients. Clin Nutr 2007; 26: 41-50.
51. Manzanares W, Biestro A, Galusso F, Torre MH, Manay N, Pittini G, Facchin G, Hardy G: Serum selenium and glutathione peroxidase-3 activity: biomarkers of systemic inflammation in the critically ill? Intensive Care Med 2008.